Back to Search
Start Over
Characterisation of Atherogenic Effects of Low Carbohydrate, High Protein Diet (LCHP) in ApoE/LDLR-/- Mice.
- Source :
-
The journal of nutrition, health & aging [J Nutr Health Aging] 2015 Aug; Vol. 19 (7), pp. 710-8. - Publication Year :
- 2015
-
Abstract
- Introduction: Low Carbohydrate High Protein diet represents a popular strategy to achieve weight loss.<br />Objective: The aim of this study was to characterize effects of low carbohydrate, high protein diet (LCHP) on atherosclerotic plaque development in brachiocephalic artery (BCA) in apoE/LDLR-/- mice and to elucidate mechanisms of proatherogenic effects of LCHP diet.<br />Materials and Methods: Atherosclerosis plaques in brachiocephalic artery (BCA) as well as in aortic roots, lipoprotein profile, inflammation biomarkers, expression of SREBP-1 in the liver as well as mortality were analyzed in Control diet (AIN-93G) or LCHP (Low Carbohydrate High Protein) diet fed mice.<br />Results: Area of atherosclerotic plaques in aortic roots or BCA from LCHP diet fed mice was substantially increased as compared to mice fed control diet and was characterized by increased lipids and cholesterol contents (ORO staining, FT-IR analysis), increased macrophage infiltration (MOMA-2) and activity of MMPs (zymography). Pro-atherogenic phenotype of LCHP fed apoE/LDLR-/- mice was associated with increased plasma total cholesterol concentration, and in LDL and VLDL fractions, increased TG contents in VLDL, and a modest increase in plasma urea. LCHP diet increased SCD-1 index, activated SREBP-1 transcription factor in the liver and triggered acute phase response as evidence by an increased plasma concentration of haptoglobin, CRP or AGP. Finally, in long-term experiment survival of apoE/LDLR-/- mice fed LCHP diet was substantially reduced as compared to their counterparts fed control diet suggesting overall detrimental effects of LCHP diet on health.<br />Conclusions: The pro-atherogenic effect of LCHP diet in apoE/LDLR-/- mice is associated with profound increase in LDL and VLDL cholesterol, VLDL triglicerides, liver SREBP-1 upregulation, and systemic inflammation.
- Subjects :
- Acute-Phase Reaction chemically induced
Animals
Aorta drug effects
Aorta pathology
Apolipoproteins E deficiency
Atherosclerosis blood
Brachiocephalic Trunk drug effects
Brachiocephalic Trunk pathology
Cholesterol, LDL blood
Cholesterol, VLDL blood
Dietary Proteins administration & dosage
Female
Inflammation chemically induced
Liver drug effects
Liver metabolism
Macrophages drug effects
Male
Mice
Mice, Knockout
Plaque, Atherosclerotic blood
Plaque, Atherosclerotic chemically induced
Receptors, LDL deficiency
Sterol Regulatory Element Binding Protein 1 metabolism
Survival Analysis
Triglycerides blood
Urea blood
Apolipoproteins E genetics
Atherosclerosis chemically induced
Diet, Atherogenic adverse effects
Diet, Carbohydrate-Restricted adverse effects
Dietary Proteins pharmacology
Receptors, LDL genetics
Subjects
Details
- Language :
- English
- ISSN :
- 1760-4788
- Volume :
- 19
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- The journal of nutrition, health & aging
- Publication Type :
- Academic Journal
- Accession number :
- 26193853
- Full Text :
- https://doi.org/10.1007/s12603-015-0543-7